tm logo
Trademark Search
SUMITOMO DAINIPPON PHARMA ONCOLOGY

View On IC.GC.CA

SUMITOMO DAINIPPON PHARMA ONCOLOGY
ABANDONED SECTION 36

on 08 Nov 2022

Last Applicant/ Owned by

SUMITOMO DAINIPPON PHARMA CO. LTD.

6-8, Doshomachi 2-chome,Chuo-ku, Osaka-shiOsaka 541-0045

JP

Serial Number

2057484 filed on 07th Jul 2020

SUMITOMO DAINIPPON PHARMA ONCOLOGY

Trademark usage description

antitumor drugs; pharmaceutical preparations for the diagnosis, prevention and treatment of cancer; biological preparations for the treatment of cance Read More

Classification Information

Class [005]
Antitumor drugs; pharmaceutical preparations for the diagnosis, prevention and treatment of cancer; biological preparations for the treatment of cancer.

Classification kind code

11

Class [042]
Testing, inspection or research of pharmaceuticals; testing, inspection or research of pharmaceuticals for the diagnosis, prevention and treatment of cancer.

Classification kind code

11

Class [044]
Providing medical information relating to pharmaceuticals; providing information in the field of cancer prevention, screening, diagnosis and treatment; health care services for treating cancer.

Classification kind code

11

Mark Details

Serial Number

2057484

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 14
on 16th Aug 2022		Default Notice Sent
Submitted for opposition 22
on 26th Jan 2022		Search Recorded
Submitted for opposition 20
on 26th Jan 2022		Examiner's First Report
Submitted for opposition 223
on 26th Jan 2022		Total Provisional Refusal
Submitted for opposition 256
on 16th Aug 2021		Notification of Possible Opposition Sent
Submitted for opposition 257
on 15th Oct 2020		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 15th Oct 2020		Formalized
Submitted for opposition 1
on 14th Oct 2020		Created
Submitted for opposition 30
on 07th Jul 2020		Filed
Submitted for opposition 228
on 07th Jul 2020		International Registration